Related Experiment Videos
[The influence of phospholine iodide on the squinting angle (author's transl)]
Klinische Monatsblatter Fur Augenheilkunde
|October 1, 1981
Insights
Phospholine iodide therapy for convergent strabismus in children showed only modest success. Potential complications outweigh the limited benefits, questioning its overall effectiveness.
Area of Science:
- Ophthalmology
- Pediatric ophthalmology
Context:
- Convergent strabismus is a common condition in pediatric patients.
- Phospholine iodide is a medication used in ophthalmology.
Purpose:
- To evaluate the efficacy and safety of phospholine iodide therapy for treating convergent strabismus in children.
Summary:
- This study analyzed 112 children treated with phospholine iodide for convergent strabismus.
- Results indicated that the therapeutic success was modest.
- The observed complications were deemed to outweigh the limited benefits.
Impact:
- Findings suggest a need for caution when considering phospholine iodide for pediatric convergent strabismus.
- Highlights the importance of risk-benefit assessment in pediatric eye care.
- May influence clinical guidelines regarding strabismus treatment options.
Abstract:
The author discusses the results of phospholine iodide therapy on 112 children with convergent strabismus and comes to the conclusion that the possible complications of this therapy are not outweighed by its only very modest success.